Market Research Logo

Accugenomics Inc - Product Pipeline Analysis, 2018 Update

Summary

Accugenomics Inc (Accugenomics) is a developer of oncology molecular diagnostics. The company develops and markets gene expression tests to diagnose and monitor cancer treatment. It offers gene expression tests including lung cancer risk test, standardized BCR-ABL molecular diagnostics test and lung cancer diagnostic test. Accugenomics’ product candidates comprise LCDT-AGx-3 Gene lung cancer diagnostic tests that help improve diagnostic precision as an adjunct to morphological criteria and LCCT-AGx-4 Gene lung cancer chemoresistance test to estimate the response of different lung cancers to cisplatin or irinotecan related treatments. The company operates through its development laboratory in Wilmington. Accugenomics is headquartered in Wilmington, North Carolina, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Accugenomics Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Accugenomics Inc Company Overview
Accugenomics Inc Company Snapshot
Accugenomics Inc Pipeline Products and Ongoing Clinical Trials Overview
Accugenomics Inc – Pipeline Analysis Overview
Accugenomics Inc - Key Facts
Accugenomics Inc - Major Products and Services
Accugenomics Inc Pipeline Products by Development Stage
Accugenomics Inc Ongoing Clinical Trials by Trial Status
Accugenomics Inc Pipeline Products Overview
AccuKit
AccuKit Product Overview
Lung Cancer Chemoresistance Test - 4 Gene
Lung Cancer Chemoresistance Test - 4 Gene Product Overview
Lung Cancer Diagnostic Test - 3 Gene
Lung Cancer Diagnostic Test - 3 Gene Product Overview
Lung Cancer Risk Test - 14 Gene
Lung Cancer Risk Test - 14 Gene Product Overview
Lung Cancer Risk Test - 15 Gene
Lung Cancer Risk Test - 15 Gene Product Overview
Lung Cancer Risk Test - 15 Gene Clinical Trial
Accugenomics Inc - Key Competitors
Accugenomics Inc - Key Employees
Accugenomics Inc - Locations And Subsidiaries
Head Office
Recent Developments
Accugenomics Inc, Recent Developments
Aug 15, 2017: AccuGenomics Provides an AccuKit to Qura Therapeutics as Part of a Research Collaboration Agreement
Jul 08, 2016: AccuGenomics presents their molecular standardization technology at GTCbio Molecular Diagnostic Conference in Boston, MA.
Jan 29, 2016: Release of lung cancer risk test trial details and establishment of biospecimen repository
Dec 18, 2015: Progress in Efforts to Develop AccuKit for Monitoring of BCR-ABL Treatment
Jul 01, 2015: STARSEQ Demonstrates Measurement of Undetected Errors that Arise in Next Generation Sequencing
Jun 11, 2015: SNAQ BCR-ABL Pilot Study Results Presented at 20th Annual European Hematology Association Meeting
Sep 07, 2014: Preliminary SNAQ BCR-ABL Pilot results presented at the 16th Annual John Goldman Conference on Chronic Myeloid Leukemia
Jul 01, 2014: AccuGenomics awarded United States patent for a molecular test that predicts lung cancer risk
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Accugenomics Inc Pipeline Products and Ongoing Clinical Trials Overview
Accugenomics Inc Pipeline Products by Equipment Type
Accugenomics Inc Pipeline Products by Indication
Accugenomics Inc Ongoing Clinical Trials by Trial Status
Accugenomics Inc, Key Facts
Accugenomics Inc, Major Products and Services
Accugenomics Inc Number of Pipeline Products by Development Stage
Accugenomics Inc Pipeline Products Summary by Development Stage
Accugenomics Inc Ongoing Clinical Trials by Trial Status
Accugenomics Inc Ongoing Clinical Trials Summary
AccuKit - Product Status
AccuKit - Product Description
Lung Cancer Chemoresistance Test - 4 Gene - Product Status
Lung Cancer Chemoresistance Test - 4 Gene - Product Description
Lung Cancer Diagnostic Test - 3 Gene - Product Status
Lung Cancer Diagnostic Test - 3 Gene - Product Description
Lung Cancer Risk Test - 14 Gene - Product Status
Lung Cancer Risk Test - 14 Gene - Product Description
Lung Cancer Risk Test - 15 Gene - Product Status
Lung Cancer Risk Test - 15 Gene - Product Description
Lung Cancer Risk Test - 15 Gene - Validation of a Multi-gene Test for Lung Cancer Risk
Accugenomics Inc, Key Employees
Glossary
List of Figures
Accugenomics Inc Pipeline Products by Equipment Type
Accugenomics Inc Pipeline Products by Development Stage
Accugenomics Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report